|
1
|
van Dongen JA, Voogd AC, Fentiman IS,
Legrand C, Sylvester RJ, Tong D, van der Schueren E, Helle PA, van
Zijl K and Bartelink H: Long-term results of a randomized trial
comparing breast-conserving therapy with mastectomy: European
organization for research and treatment of cancer 10801 trial. J
Natl Cancer Inst. 92:1143–1150. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Morris AD, Morris RD, Wilson JF, White J,
Steinberg S, Okunieff P, Arriagada R, Lê MG, Blichert-Toft M and
van Dongen JA: Breast-conserving therapy vs mastectomy in
early-stage breast cancer: A meta-analysis of 10-year survival.
Cancer J Sci Am. 3:6–12. 1997.PubMed/NCBI
|
|
3
|
Clarke M, Collins R, Darby S, Davies C,
Elphinstone P, Evans V, Godwin J, Gray R, Hicks C, James S, et al:
Effects of radiotherapy and of differences in the extent of surgery
for early breast cancer on local recurrence and 15-year survival:
An overview of the randomised trials. Lancet. 366:2087–2106. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Veronesi U, Cascinelli N, Mariani L, Greco
M, Saccozzi R, Luini A, Aguilar M and Marubini E: Twenty-year
follow-up of a randomized study comparing breast-conserving surgery
with radical mastectomy for early breast cancer. N Engl J Med.
347:1227–1232. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fisher B, Anderson S, Bryant J, Margolese
RG, Deutsch M, Fisher ER, Jeong JH and Wolmark N: Twenty-year
follow-up of a randomized trial comparing total mastectomy,
lumpectomy, and lumpectomy plus irradiation for the treatment of
invasive breast cancer. N Engl J Med. 347:1233–1241. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ishitobi M, Okumura Y, Arima N, Yoshida A,
Nakatsukasa K, Iwase T, Shien T, Masuda N, Tanaka S, Tanabe M, et
al: Breast cancer subtype and distant recurrence after ipsilateral
breast tumor recurrence. Ann Surg Oncol. 20:1886–1892. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Okumura Y, Nishimura R, Nakatsukasa K,
Yoshida A, Masuda N, Tanabe M, Shien T, Tanaka S, Arima N, Komoike
Y, et al: Change in estrogen receptor, HER2 and Ki-67 status
between primary breast cancer and ipsilateral breast cancer tumor
recurrence. Eur J Surg Oncol. 41:548–552. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wicha MS, Liu S and Dontu G: Cancer stem
cells: An old idea-a paradigm shift. Cancer Res. 66:1883–1890,
1895–1896. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ginestier C, Hur MH, CharafeJauffret E,
Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG,
Liu S, et al: ALDH1 is a marker of normal and malignant human
mammary stem cells and a predictor of poor clinical outcome. Cell
Stem Cell. 1:555–567. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Arima N, Nishimura R, Osako T, Nishiyama
Y, Fujisue M, Okumura Y, Nakano M, Tashima R and Toyozumi Y: The
importance of tissue handling of surgically removed breast cancer
for an accurate assessment of the Ki-67 index. J Clin Pathol.
69:255–259. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Arima N, Nishimura R, Osako T, Nishiyama
Y, Fujisue M, Okumura Y, Nakano M, Tashima R and Toyozumi Y: A
comparison of the hot spot and the average cancer cell counting
methods and the optimal cutoff point of the Ki-67 index for luminal
type breast cancer. Oncology. 90:43–50. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nogami T, Shien T, Tanaka T, Nishiyama K,
Mizoo T, Iwamto T, Ikeda H, Taira N, Doihara H and Miyoshi S:
Expression of ALDH1 in axillary lymph node metastases is a
prognostic factor of poor clinical outcome in breast cancer
patients with 1–3 lymph node metastases. Breast Cancer. 21:58–65.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ito M, Shien T, Omori M, Mizoo T, Iwamoto
T, Nogami T, Motoki T, Taira N, Doihara H and Miyoshi S: Evaluation
of aldehyde dehydrogenase 1 and transcription factors in both
primary breast cancer and axillary lymph node metastases as a
prognostic factor. Breast Cancer. 23:437–444. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nogami T, Shien T, Tanaka T, Doihara H,
Taira N, Takabatake D, Nishimura R, Nishiyama K, Mizoo T and Ohsumi
S: The discordance between primary breast cancer lesions and
pulmonary metastatic lesions in expression of aldehyde
dehydrogenase 1-positive cancer cells. Breast Cancer. 21:698–702.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yeung C, Hilton J, Clemons M, Mazzarello
S, Hutton B, Haggar F, Addison CL, Kuchuk I, Zhu X, Gelmon K and
Arnaout A: Estrogen, progesterone, and HER2/neu receptor
discordance between primary and metastatic breast tumours-a review.
Cancer Metastasis Rev. 35:427–437. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rossi S, Basso M, Strippoli A, Dadduzio V,
Cerchiaro E, Barile R, D'Argento E, Cassano A, Schinzari G and
Barone C: Hormone receptor status and HER2 expression in primary
breast cancer compared with synchronous Axillary metastases or
recurrent metastatic disease. Clin Breast Cancer. 15:307–312. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shien K, Toyooka S, Ichimura K, Soh J,
Furukawa M, Maki Y, Muraoka T, Tanaka N, Ueno T, Asano H, et al:
Prognostic impact of cancer stem cell-related markers in non-small
cell lung cancer patients treated with induction chemoradiotherapy.
Lung Cancer. 77:162–167. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tanei T, Morimoto K, Shimazu K, Kim SJ,
Tanji Y, Taguchi T, Tamaki Y and Noguchi S: Association of breast
cancer stem cells identified by aldehyde dehydrogenase 1 expression
with resistance to sequential paclitaxel and epirubicin-based
chemotherapy for breast cancers. Clin Cancer Res. 15:4234–4241.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Benson JR and Rovere GQ della: Ipsilateral
breast cancer recurrence. Breast. 17:12–18. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen SL and Martinez SR: The survival
impact of the choice of surgical procedure after ipsilateral breast
cancer recurrence. Am J Surg. 196:495–499. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McGrath S, Antonucci J, Goldstein N,
Wallace M, Mitchell C, Grills I, Jolly S, Kestin L and Vicini F:
Long-term patterns of in-breast failure in patients with early
stage breast cancer treated with breast-conserving therapy: A
molecular based clonality evaluation. Am J Clin Oncol. 33:17–22.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhong Y, Lin Y, Shen S, Zhou Y, Mao F,
Guan J and Sun Q: Expression of ALDH1 in breast invasive ductal
carcinoma: An independent predictor of early tumor relapse. Cancer
Cell Int. 13:602013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ohi Y, Umekita Y, Yoshioka T, Souda M, Rai
Y, Sagara Y, Sagara Y, Sagara Y and Tanimoto A: Aldehyde
dehydrogenase 1 expression predicts poor prognosis in
triple-negative breast cancer. Histopathology. 59:776–780. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou L, Li K, Luo Y, Tian L, Wang M, Li C
and Huang Q: Novel prognostic markers for patients with
triple-negative breast cancer. Hum Pathol. 44:2180–2187. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Moja L, Tagliabue L, Balduzzi S, Parmelli
E, Pistotti V, Guarneri V and D'Amico R: Trastuzumab containing
regimens for early breast cancer. Cochrane Database Syst Rev.
18:CD0062432012.
|
